A young adult clinic to support integration into adult sickle cell disease care: If you build it, they will come
- 3 March 2025
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 206 (5) , 1458-1465
Abstract
Summary: In high‐income countries, individuals with sickle cell disease (SCD) almost universally survive into adulthood, but transfer to adult SCD care is fraught. The young adult clinic (YAC) at our sickle cell centre was designed to provide developmentally appropriate, expert SCD care to young adults with SCD aged 18–30 years. In this retrospective cohort study, we measured YAC appointment attendance and scheduling attempts based on patient referral source and demographic characteristics. Between 1 March 2019 and 30 September 2023, 89% (170/192) of referred patients attended a YAC appointment, and 97% (77/79) of patients referred from paediatric SCD care attended a YAC appointment. Most patients attended their first scheduled appointment (61%, 105/170). Among rescheduled patients, the mean number of scheduling attempts before attendance was 2.9 (standard deviation 1.5). During the 55‐month study period, this cohort had five deaths (3%) and seven successful haematopoietic stem cell transplants (4%). These results indicate that healthcare systems designed to meet the needs of young adults with SCD enable successful participation in adult SCD care. Resources to build robust adult SCD care systems are desperately needed, alongside research regarding optimal approaches to integrating young people into adult SCD care.Keywords
Funding Information
- Andrew W. Mellon Foundation
- National Heart, Lung, and Blood Institute (K23HL146841)
- National Heart, Lung, and Blood Institute (U01 HL156620‐01)
This publication has 29 references indexed in Scilit:
- Psychiatry referral and appointment attendance in a clinic for young adults with sickle cell diseasePediatric Blood & Cancer, 2024
- How young adults with sickle cell disease define “being a good patient” in the adult healthcare systemPediatric Blood & Cancer, 2023
- Assessing barriers and facilitators to transition in sickle cell disease care prior to implementation of a formalized programPediatric Blood & Cancer, 2023
- Treatment patterns and burden of complications associated with sickle cell disease: A US retrospective claims analysiseJHaem, 2022
- Converting adults with sickle cell disease from full agonist opioids to buprenorphine: A reliable method with safety and early evidence of reduced acute care utilizationAmerican Journal of Hematology, 2022
- Transition care continuity promotes long‐term retention in adult care among young adults with sickle cell diseasePediatric Blood & Cancer, 2021
- Impact of a transition program with navigator on loss to follow‐up, medication adherence, and appointment attendance in hemoglobinopathiesPediatric Blood & Cancer, 2019
- Transition to adult care in sickle cell disease: A longitudinal study of clinical characteristics and disease severityPediatric Blood & Cancer, 2018
- Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisisAmerican Journal of Hematology, 2015
- Age‐related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costsPediatric Blood & Cancer, 2013